StreetInsider.com News Articles

Form 4 Precipio, Inc. For: May 21 Filed by: SANDBERG RICHARD A

Tue, 26 May 2026 16:00:00 -0400

si-local-file:///var/storage/secattach/20260526/26549625.html

Form 4 Precipio, Inc. For: May 21 Filed by: SANDBERG RICHARD A

Tue, 26 May 2026 16:00:00 -0400

si-local-file:///var/storage/secattach/20260526/26549625.html

Form 4 Precipio, Inc. For: May 19 Filed by: SANDBERG RICHARD A

Thu, 21 May 2026 16:00:00 -0400

si-local-file:///var/storage/secattach/20260521/26534997.html

Form 4 Precipio, Inc. For: May 19 Filed by: SANDBERG RICHARD A

Thu, 21 May 2026 16:00:00 -0400

si-local-file:///var/storage/secattach/20260521/26534997.html

Form 144 Precipio, Inc. Filed by: SANDBERG RICHARD A

Tue, 19 May 2026 14:20:00 -0400

si-local-file:///var/storage/secattach/20260519/26520354.html

Form 144 Precipio, Inc. Filed by: SANDBERG RICHARD A

Tue, 19 May 2026 14:20:00 -0400

si-local-file:///var/storage/secattach/20260519/26520354.html

Precipio Announces Q1 2026 Financial Results

Thu, 14 May 2026 17:00:00 -0400

NEW HAVEN, Conn., May 14, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), announces financial results for the first quarter ended March 31, 2026.

Below are some of the key financial performance metrics for the Company. Please see the Company’s Form 10-Q which was filed today for additional details.

Revenue – $6.71M (vs. $6.69M in Q4-2025; $4.93M in Q1-2025). This was comprised of $6.05M in pathology revenue (up from $5.9M in Q4) and $0.66M

Precipio Announces Q1 2026 Financial Results

Thu, 14 May 2026 17:00:00 -0400

NEW HAVEN, Conn., May 14, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), announces financial results for the first quarter ended March 31, 2026.

Below are some of the key financial performance metrics for the Company. Please see the Company’s Form 10-Q which was filed today for additional details.

Revenue – $6.71M (vs. $6.69M in Q4-2025; $4.93M in Q1-2025). This was comprised of $6.05M in pathology revenue (up from $5.9M in Q4) and $0.66M

Precipio Announces Q1 2026 Financial Results

Thu, 14 May 2026 17:00:00 -0400

NEW HAVEN, Conn., May 14, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), announces financial results for the first quarter ended March 31, 2026.

Below are some of the key financial performance metrics for the Company. Please see the Company’s Form 10-Q which was filed today for additional details.

Revenue – $6.71M (vs. $6.69M in Q4-2025; $4.93M in Q1-2025). This was comprised of $6.05M in pathology revenue (up from $5.9M in Q4) and $0.66M

Precipio Announces Q1 2026 Financial Results

Thu, 14 May 2026 17:00:00 -0400

NEW HAVEN, Conn., May 14, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), announces financial results for the first quarter ended March 31, 2026.

Below are some of the key financial performance metrics for the Company. Please see the Company’s Form 10-Q which was filed today for additional details.

Revenue – $6.71M (vs. $6.69M in Q4-2025; $4.93M in Q1-2025). This was comprised of $6.05M in pathology revenue (up from $5.9M in Q4) and $0.66M

Form 10-Q Precipio, Inc. For: Mar 31

Thu, 14 May 2026 16:17:00 -0400

si-local-file:///var/storage/secattach/20260514/26495260.html

Form 10-Q Precipio, Inc. For: Mar 31

Thu, 14 May 2026 16:17:00 -0400

si-local-file:///var/storage/secattach/20260514/26495260.html

Management team’s 2025 market-based Options have vested

Wed, 13 May 2026 17:00:00 -0400

NEW HAVEN, Conn., May 13, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) announces that 2025 employee stock options granted to certain members of Precipio’s management team vested last week because the Company’s Common Stock price increased by more than 400% since the options were granted.

As proposed by the Company’s Compensation Committee in late 2024, rather than the standard 4-year time-based vesting period, management was offered and agreed to a market-based vesting structure whereby the options fully vest once the Company’s share price exceeds

Management team’s 2025 market-based Options have vested

Wed, 13 May 2026 17:00:00 -0400

Management team’s 2025 market-based Options have vested

Wed, 13 May 2026 17:00:00 -0400

Management team’s 2025 market-based Options have vested

Wed, 13 May 2026 17:00:00 -0400

Form 8-K Precipio, Inc. For: May 06

Wed, 06 May 2026 17:16:00 -0400

si-local-file:///var/storage/secattach/20260506/26445474.html

Form 8-K Precipio, Inc. For: May 06

Wed, 06 May 2026 17:16:00 -0400

si-local-file:///var/storage/secattach/20260506/26445474.html

Precipio Announces Q1-2026 Shareholder Update Call

Wed, 06 May 2026 17:00:00 -0400

NEW HAVEN, Conn., May 06, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its Q1-2026 shareholder update call on May 18th, 2026, at 5:00 PM ET. The call will include remarks on the company’s current core businesses, as well as a moderated live Q&A session at the end of the Company remarks.

As part of Precipio’s ongoing commitment to transparency and shareholder engagement, this call will be the first time the Company will incorporate a dedicated moderated live Q&A session into

Precipio Announces Q1-2026 Shareholder Update Call

Wed, 06 May 2026 17:00:00 -0400

As part of Precipio’s ongoing commitment to transparency and shareholder engagement, this call will be the first time the Company will incorporate a dedicated moderated live Q&A session into

Precipio Announces Q1-2026 Shareholder Update Call

Wed, 06 May 2026 17:00:00 -0400

As part of Precipio’s ongoing commitment to transparency and shareholder engagement, this call will be the first time the Company will incorporate a dedicated moderated live Q&A session into

Precipio Announces Q1-2026 Shareholder Update Call

Wed, 06 May 2026 17:00:00 -0400

As part of Precipio’s ongoing commitment to transparency and shareholder engagement, this call will be the first time the Company will incorporate a dedicated moderated live Q&A session into

Form ARS Precipio, Inc. For: Dec 31

Tue, 28 Apr 2026 16:33:00 -0400

si-local-file:///var/storage/secattach/20260428/26384732.html

Form ARS Precipio, Inc. For: Dec 31

Tue, 28 Apr 2026 16:33:00 -0400

si-local-file:///var/storage/secattach/20260428/26384732.html

Form DEFA14A Precipio, Inc.

Tue, 28 Apr 2026 16:32:00 -0400

si-local-file:///var/storage/secattach/20260428/26384704.html